Skip to main content
. 2020 Jun 11;9(10):1163–1173. doi: 10.1002/sctm.20-0186

FIGURE 3.

FIGURE 3

Sources of human MSCs used in immune/inflammatory lung disease clinical trials. Number of trials using different sources of human MSCs is shown, and whether sources are autologous (AUTO‐MSC), allogeneic (ALLO‐MSC), unspecified (UNSP‐MSC), and/or noncell exosomes/conditioned medium (MSC‐derived products). Data accessed on May 2020 from the NIH Clinical Trial website (https://ClinicalTrials.gov/). MSC, mesenchymal stem cell